CNS Therapeutics Market Insights Video

According to Cognitive Market Research, the global CNS Therapeutics market size will be USD 1,52,849.6 million in 2025. It will expand at a compound annual growth rate (CAGR) of 11.20% from 2025 to 2033.

• North America held the major market share for more than 37% of the global revenue with a market size of USD 56554.35 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2033.
• Europe accounted for a market share of over 29% of the global revenue with a market size of USD 44326.38 million.
• APAC held a market share of around 24% of the global revenue with a market size of USD 36683.90 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2033.
• South America has a market share of more than 3.8% of the global revenue with a market size of USD 5808.28 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2033.
• Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 6113.98 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2033.
• Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 3362.69 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2033.
• Calcium is the fastest growing segment of the CNS Therapeutics industry